148 related articles for article (PubMed ID: 37865337)
1. Trimethoprim-sulfamethoxazole significantly reduces the risk of nocardiosis in solid organ transplant recipients: systematic review and individual patient data meta-analysis.
Passerini M; Nayfeh T; Yetmar ZA; Coussement J; Goodlet KJ; Lebeaux D; Gori A; Mahmood M; Temesgen Z; Murad MH
Clin Microbiol Infect; 2024 Feb; 30(2):170-177. PubMed ID: 37865337
[TBL] [Abstract][Full Text] [Related]
2. Trimethoprim/sulfamethoxazole for nocardiosis in solid organ transplant recipients: Real-life data from a multicentre retrospective study.
Conan PL; Matignon M; Bleibtreu A; Guillot H; Van Laecke S; Brenier H; Crochette R; Melica G; Fernández-Ruiz M; Dantal J; Walti LN; Levi C; Chauvet C; De Greef J; Marbus SD; Mueller NJ; Ieven M; Vuotto F; Lortholary O; Coussement J; Lebeaux D
Transpl Infect Dis; 2021 Aug; 23(4):e13669. PubMed ID: 34143917
[TBL] [Abstract][Full Text] [Related]
3. Risk factors and prophylaxis for nocardiosis in solid organ transplant recipients: A nested case-control study.
Yetmar ZA; Chesdachai S; Duffy D; Smith BH; Challener DW; Seville MT; Bosch W; Beam E
Clin Transplant; 2023 Sep; 37(9):e15016. PubMed ID: 37170686
[TBL] [Abstract][Full Text] [Related]
4. A 20-year experience with nocardiosis in solid organ transplant (SOT) recipients in the Southwestern United States: A single-center study.
Majeed A; Beatty N; Iftikhar A; Mushtaq A; Fisher J; Gaynor P; Kim JC; Marquez JL; Mora FE; Georgescu A; Zangeneh T
Transpl Infect Dis; 2018 Aug; 20(4):e12904. PubMed ID: 29668074
[TBL] [Abstract][Full Text] [Related]
5. Recurrent nocardiosis in solid organ transplant recipients: An evaluation of secondary prophylaxis.
Yetmar ZA; Wilson JW; Beam E
Transpl Infect Dis; 2021 Dec; 23(6):e13753. PubMed ID: 34724316
[TBL] [Abstract][Full Text] [Related]
6. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
[TBL] [Abstract][Full Text] [Related]
7. Nocardia prophylaxis, treatment, and outcomes of infection in lung transplant recipients: A matched case-control study.
Goodlet KJ; Tokman S; Nasar A; Cherrier L; Walia R; Nailor MD
Transpl Infect Dis; 2021 Apr; 23(2):e13478. PubMed ID: 32989873
[TBL] [Abstract][Full Text] [Related]
8. Nocardia Infection in Solid Organ Transplant Recipients: A Multicenter European Case-control Study.
Coussement J; Lebeaux D; van Delden C; Guillot H; Freund R; Marbus S; Melica G; Van Wijngaerden E; Douvry B; Van Laecke S; Vuotto F; Tricot L; Fernández-Ruiz M; Dantal J; Hirzel C; Jais JP; Rodriguez-Nava V; Lortholary O; Jacobs F;
Clin Infect Dis; 2016 Aug; 63(3):338-45. PubMed ID: 27090987
[TBL] [Abstract][Full Text] [Related]
9. Risk Factors and Outcomes of Nocardiosis in Hematopoietic Stem Cell Transplantation Recipients.
Yetmar ZA; Thoendel MJ; Bosch W; Seville MT; Hogan WJ; Beam E
Transplant Cell Ther; 2023 Mar; 29(3):206.e1-206.e7. PubMed ID: 36526261
[TBL] [Abstract][Full Text] [Related]
10. Outcomes of transplant recipients with pretransplant Nocardia colonization or infection.
Yetmar ZA; Chesdachai S; Khodadadi RB; McHugh JW; Challener DW; Wengenack NL; Bosch W; Seville MT; Beam E
Transpl Infect Dis; 2023 Oct; 25(5):e14097. PubMed ID: 37378539
[TBL] [Abstract][Full Text] [Related]
11. Increased Incidence of Nocardial Infections in an Era of Atovaquone Prophylaxis in Allogeneic Hematopoietic Stem Cell Transplant Recipients.
Molina A; Winston DJ; Pan D; Schiller GJ
Biol Blood Marrow Transplant; 2018 Aug; 24(8):1715-1720. PubMed ID: 29555315
[TBL] [Abstract][Full Text] [Related]
12. Alternative pneumocystis prophylaxis in solid organ transplant recipients at two large transplant centers.
Lum J; Echenique I; Athans V; Koval CE
Transpl Infect Dis; 2021 Feb; 23(1):e13461. PubMed ID: 32894607
[TBL] [Abstract][Full Text] [Related]
13. Nocardia infections in the transplanted host.
Hemmersbach-Miller M; Stout JE; Woodworth MH; Cox GM; Saullo JL
Transpl Infect Dis; 2018 Aug; 20(4):e12902. PubMed ID: 29668123
[TBL] [Abstract][Full Text] [Related]
14. Prophylaxis of urinary tract infection in persons with recent spinal cord injury: a prospective, randomized, double-blind, placebo-controlled study of trimethoprim-sulfamethoxazole.
Gribble MJ; Puterman ML
Am J Med; 1993 Aug; 95(2):141-52. PubMed ID: 8356980
[TBL] [Abstract][Full Text] [Related]
15. Nocardiosis following hematopoietic stem cell transplantation.
Shannon K; Pasikhova Y; Ibekweh Q; Ludlow S; Baluch A
Transpl Infect Dis; 2016 Apr; 18(2):169-75. PubMed ID: 26809666
[TBL] [Abstract][Full Text] [Related]
16. The impact of trimethoprim-sulfamethoxazole as Pneumocystis jiroveci pneumonia prophylaxis on the occurrence of asymptomatic bacteriuria and urinary tract infections among renal allograft recipients: a retrospective before-after study.
Singh R; Bemelman FJ; Hodiamont CJ; Idu MM; Ten Berge IJ; Geerlings SE
BMC Infect Dis; 2016 Feb; 16():90. PubMed ID: 26912326
[TBL] [Abstract][Full Text] [Related]
17. Tolerability of low-dose sulfamethoxazole/trimethoprim for Pneumocystis jirovecii pneumonia prophylaxis in kidney transplant recipients.
Zmarlicka M; Martin ST; Cardwell SM; Nailor MD
Prog Transplant; 2015 Sep; 25(3):210-6. PubMed ID: 26308779
[TBL] [Abstract][Full Text] [Related]
18. Risk factors for Nocardia infection among allogeneic hematopoietic cell transplant recipients: A case-control study of the Infectious Diseases Working Party of the European Society for Blood and Marrow Transplantation.
De Greef J; Averbuch D; Tondeur L; Duréault A; Zuckerman T; Roussel X; Robin C; Xhaard A; Pagliuca S; Beguin Y; Botella-Garcia C; Khanna N; Le Bourgeois A; Van Praet J; Ho A; Kröger N; Ducastelle Leprêtre S; Roos-Weil D; Aljurf M; Blijlevens N; Blau IW; Carlson K; Collin M; Ganser A; Villate A; Lakner J; Martin S; Nagler A; Ram R; Torrent A; Stamouli M; Mikulska M; Gil L; Wendel L; Tridello G; Knelange N; de la Camara R; Lortholary O; Fontanet A; Styczynski J; Maertens J; Coussement J; Lebeaux D
J Infect; 2024 Jun; 88(6):106162. PubMed ID: 38663756
[TBL] [Abstract][Full Text] [Related]
19. Epidemiology and risk factors associated with Pneumocystis jirovecii pneumonia in kidney transplant recipients after 6-month trimethoprim-sulfamethoxazole prophylaxis: A case-control study.
Park SY; Jung JH; Kwon H; Shin S; Kim YH; Chong YP; Lee SO; Choi SH; Kim YS; Woo JH; Kim SH; Han DJ
Transpl Infect Dis; 2020 Apr; 22(2):e13245. PubMed ID: 31943590
[TBL] [Abstract][Full Text] [Related]
20. Sulfonamide desensitization in solid organ transplant recipients: A protocol-driven approach during the index transplant hospitalization.
Pryor JB; Olyaei AJ; Kirsch D; Strasfeld L
Transpl Infect Dis; 2019 Dec; 21(6):e13191. PubMed ID: 31596538
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
